Your browser doesn't support javascript.
loading
Atomoxetine restores the response inhibition network in Parkinson's disease.
Rae, Charlotte L; Nombela, Cristina; Rodríguez, Patricia Vázquez; Ye, Zheng; Hughes, Laura E; Jones, P Simon; Ham, Timothy; Rittman, Timothy; Coyle-Gilchrist, Ian; Regenthal, Ralf; Sahakian, Barbara J; Barker, Roger A; Robbins, Trevor W; Rowe, James B.
Afiliação
  • Rae CL; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK.
  • Nombela C; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Rodríguez PV; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Ye Z; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Hughes LE; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK.
  • Jones PS; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Ham T; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Rittman T; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Coyle-Gilchrist I; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Regenthal R; 3 Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, 04107, Germany.
  • Sahakian BJ; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 5 Department of Psychiatry, University of Cambridge, CB2 0SZ, Cambridge, UK.
  • Barker RA; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.
  • Robbins TW; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 6 Department of Experimental Psychology, University of Cambridge, CB2 3EB, Cambridge, UK.
  • Rowe JB; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK james.rowe@mrc-cbu.cam.ac.uk.
Brain ; 139(Pt 8): 2235-48, 2016 08.
Article em En | MEDLINE | ID: mdl-27343257
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Índice de Gravidade de Doença / Dopaminérgicos / Avaliação de Resultados em Cuidados de Saúde / Córtex Pré-Frontal / Inibidores da Captação Adrenérgica / Corpo Estriado / Função Executiva / Cloridrato de Atomoxetina / Inibição Psicológica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Índice de Gravidade de Doença / Dopaminérgicos / Avaliação de Resultados em Cuidados de Saúde / Córtex Pré-Frontal / Inibidores da Captação Adrenérgica / Corpo Estriado / Função Executiva / Cloridrato de Atomoxetina / Inibição Psicológica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido